Global Filgrastim Market, By Type of Manufacturing (In-House Manufacturing, Contract Manufacturing), By Application (Blood Disorder, Oncology, Infectious Diseases, Others), By Region (North America, Eastern Europe, Western Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028)

Filgrastim Market is projected to register high demand during the forecast period with increasing demand from major applications such as blood disorder, oncology, infectious diseases, and others during the forecast period. Filgrastim is a special type of medication that is injected through veins or under skin for the treatment of low blood neutrophils. It is a granulocyte colony stimulating factor that increases stem cells and helps in the prevention of infections and neutropenic fever that may occur during the treatment of HIV/AIDS, cancer, radiation, etc. It has come to a vast use in the medical field and has been effective during major treatments.

The growth of the geriatric population and increasing number of various diseases, among them, is the key factor driving the global filgrastim market. The increase in the number of cancer patients in countries such as China, India, etc., is also anticipated to fuel the growth of the global filgrastim market. Increasing awareness among government agencies and ongoing biosimilar research are also expected to drive the market during the forecast period.

Key Factors Impacting Market Growth:

  • Growth in geriatric population and prevalence of various diseases
  • Increase in the number of cancer patients
  • Increasing awareness and R&D activities

Regional Outlook:

North America, Western Europe, and Asia Pacific by region are estimated to dominate the filgrastim market during the forecast period. These regions have been market leaders for the overall healthcare sector in terms of technological developments and advanced medical treatments. Moreover, the government policies have been favorable for the growth of the healthcare infrastructure in these regions. North America and Western Europe have an established healthcare infrastructure for product innovations and early adaptations. This is expected to drive the demand for filgrastim market during the forecast period. 

The US, Germany, France, UK, Canada, and Spain have been some the major markets in the region. Asia Pacific is estimated to register one of highest CAGR for filgrastim market during the forecast period. This region has witnessed strategic investments by global companies to cater the growing demand in the recent years. China, Japan, India, South Korea, and Australia are amongst some of the key countries for filgrastim market in the region. Other regions including Middle East, Eastern Europe, and Rest of the World (South America and Africa) are estimated to be emerging markets for filgrastim during the forecast period.

Companies Covered: Dr. Reddy’s Laboratories Inc., Abbott Laboratories Inc., Reliance Life Sciences Pvt. Ltd, Biocon Ltd, Cadila Pharmaceuticals Ltd…

Market Segmentation:

By Type of Manufacturing:

  • In-House Manufacturing
  • Contract Manufacturing

By Application:

  • Blood Disorder
  • Oncology
  • Infectious Diseases
  • Others

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type of Manufacturing
    • By Application
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Type of Manufacturing
    • By Application
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Type of Manufacturing
    • By Application
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Type of Manufacturing
    • By Application
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Type of Manufacturing
    • By Application
  • Rest of the World
    • By Region (South America, Africa)
    • By Type of Manufacturing
    • By Application

Reasons To Buy This Report:

  • Market size estimation of the global filgrastim market on regional and global basis
  • Unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com